(Q38136068)

English

Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines

scientific article published on April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 August 2017

Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines (English)

1 reference

Europe PubMed Central

29 August 2017

author name string

Yasuhiro Kodera

1

1 reference

Europe PubMed Central

29 August 2017

Kazumasa Fujitani

2

1 reference

Europe PubMed Central

29 August 2017

Norimasa Fukushima

3

1 reference

Europe PubMed Central

29 August 2017

Seiji Ito

4

1 reference

Europe PubMed Central

29 August 2017

Kei Muro

5

1 reference

Europe PubMed Central

29 August 2017

Norifumi Ohashi

6

1 reference

Europe PubMed Central

29 August 2017

Takaki Yoshikawa

7

1 reference

Europe PubMed Central

29 August 2017

Daisuke Kobayashi

8

1 reference

Europe PubMed Central

29 August 2017

Chie Tanaka

9

1 reference

Europe PubMed Central

29 August 2017

Michitaka Fujiwara

10

1 reference

Europe PubMed Central

29 August 2017

publication date

1 April 2014

1 reference

Europe PubMed Central

29 August 2017

1 reference

Europe PubMed Central

29 August 2017

17

1 reference

Europe PubMed Central

29 August 2017

2

1 reference

Europe PubMed Central

29 August 2017

206-212

1 reference

Europe PubMed Central

29 August 2017

https://scigraph.springernature.com/pub.10.1007/s10120-013-0299-x

0 references

Treatment for colorectal liver metastases: a review

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Is liver resection justified for patients with hepatic metastases from breast cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Liver resection for metastatic gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile?

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Outcome of operative therapy of hepatic metastatic stomach carcinoma: a retrospective analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis?

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis : imaging for recurrent colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases: a pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Treatment of multiple liver metastasis from gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Right gastric artery embolization to prevent acute gastric mucosal lesions in patients undergoing repeat hepatic arterial infusion chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Radiofrequency ablation for metachronous hepatic metastases from gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10120-013-0299-X

21 January 2018

Benefits and limits of hepatic resection for gastric metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of combined administration of 5-fluorouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Japanese gastric cancer treatment guidelines 2010 (ver. 3).

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of hepatectomy for patients with liver metastases of gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The number of metastatic lymph nodes is a significant risk factor for bone metastasis and poor outcome after surgery for linitis plastica-type gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic resection for metastatic tumors from gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of surgical treatment of liver metastases from gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indication for hepatic resection in the treatment of liver metastasis from gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24022130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10120-013-0299-X

1 reference

Europe PubMed Central

29 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

29 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38136068&oldid=1743363993"